House Bill Aims To Rein In State Drug, Device Inspections

Law360, Washington (February 23, 2012, 7:36 PM ET) -- Rep. Brian Bilbray, R-Calif., introduced a bill last week that would keep states from requiring drug and medical device makers to undergo inspections that duplicate those already deemed necessary by the U.S. Food and Drug Administration.

The bill, H.R 4056, introduced Feb. 16, would clarify areas in the Federal Food, Drug and Cosmetic Act to delineate what inspections are governed by the FDA rather than state public health departments, including facility inspections and product recalls.

Although California is the only state that requires life sciences companies...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required